10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,810,819 | -29.3% | 43,876 | -4.3% | 0.00% | -25.0% |
| Q2 2023 | $2,560,200 | +16.8% | 45,849 | +16.7% | 0.00% | 0.0% |
| Q1 2023 | $2,191,052 | +163.6% | 39,280 | +72.3% | 0.00% | +100.0% |
| Q4 2022 | $831,318 | +78.8% | 22,802 | +39.8% | 0.00% | +100.0% |
| Q3 2022 | $465,000 | -64.8% | 16,308 | -46.6% | 0.00% | -66.7% |
| Q2 2022 | $1,321,000 | -40.0% | 30,529 | +5.5% | 0.00% | -25.0% |
| Q1 2022 | $2,202,000 | -29.0% | 28,948 | +39.1% | 0.00% | -33.3% |
| Q4 2021 | $3,100,000 | -9.9% | 20,812 | -11.9% | 0.01% | -14.3% |
| Q3 2021 | $3,439,000 | -25.8% | 23,626 | -0.1% | 0.01% | -30.0% |
| Q2 2021 | $4,633,000 | +16.5% | 23,659 | +7.7% | 0.01% | 0.0% |
| Q1 2021 | $3,976,000 | +865.0% | 21,967 | +654.4% | 0.01% | +900.0% |
| Q4 2020 | $412,000 | – | 2,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |